SEC Form 4 · accession 0001209191-18-030229
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wilhelmus Cm Groenhuysen
Officer — Chief Financial Officer
Period of report
May 11, 2018
Accepted (ET)
May 15, 2018 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 11, 2018 | S | 6,693 | $30.00 | D | 201,898 | D | |
| Ordinary SharesF1 | May 11, 2018 | S | 2,700 | $30.025 | D | 199,198 | D | |
| Ordinary SharesF1 | May 14, 2018 | S | 10,008 | $30.00 | D | 189,190 | D | |
| Ordinary SharesF1 | May 14, 2018 | S | 3,590 | $30.05 | D | 185,600 | D | |
| Ordinary SharesF1 | May 14, 2018 | S | 100 | $30.075 | D | 185,500 | D | |
| Ordinary SharesF1 | May 14, 2018 | S | 4,927 | $30.10 | D | 180,573 | D | |
| Ordinary SharesF1 | May 14, 2018 | S | 1,772 | $30.15 | D | 178,801 | D | |
| Ordinary SharesF1 | May 14, 2018 | S | 200 | $30.20 | D | 178,601 | D | |
| Ordinary SharesF1 | May 14, 2018 | S | 200 | $30.225 | D | 178,401 | D | |
| Ordinary SharesF1 | May 14, 2018 | S | 280 | $30.25 | D | 178,121 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.